Recombinant UPF0114 protein BCI_0033 (BCI_0033)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in your order notes if necessary. We will fulfill requests to the best of our ability.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and agreed upon in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Repeated freeze-thaw cycles should be avoided.
Tag Info
The tag type is determined during the manufacturing process.
The specific tag type is finalized during production. If you require a particular tag, please inform us, and we will prioritize its development.
Synonyms
BCI_0033; UPF0114 protein BCI_0033
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-164
Protein Length
full length protein
Species
Baumannia cicadellinicola subsp. Homalodisca coagulata
Target Names
BCI_0033
Target Protein Sequence
MNKIIEKMIYESRWLLFPVYIGLSFGFILLTLKFFHEIIQFLPKIFDMPESDLILIVLSM IDIALVGGLLVMVMFSGYENFILKMSDDCNQKRLNWMGKMDVNSIKNKVASSIVAISSVH LLRIFMEADRTRDNKIMWCVIIHLAFVLSAFGMAYIDKMSKTKS
Uniprot No.

Target Background

Database Links

KEGG: bci:BCI_0033

Protein Families
UPF0114 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What expression systems are suitable for producing recombinant UPF0114 protein BCI_0033?

Several expression systems can be used to produce recombinant UPF0114 protein BCI_0033:

Expression HostYieldTurnaround TimePost-translational Modifications
E. coliHighShortMinimal
YeastHighShort-MediumSome
Insect cellsMediumMediumMore extensive
Mammalian cellsVariableLongMost comprehensive

What storage conditions are recommended for maintaining stability of recombinant UPF0114 protein BCI_0033?

For optimal stability, the following storage conditions are recommended:

  • Long-term storage: Store at -20°C or -80°C in aliquots to prevent repeated freeze-thaw cycles

  • Working aliquots: Store at 4°C for up to one week

  • Reconstitution buffer: Tris/PBS-based buffer, pH 8.0, containing 6% trehalose

  • For extended storage: Add glycerol to a final concentration of 50%

Repeated freeze-thaw cycles should be avoided as they may lead to protein degradation and loss of activity . For reconstitution, it is recommended to briefly centrifuge the vial prior to opening and reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL .

How should researchers design experiments to evaluate the functional properties of UPF0114 protein BCI_0033?

When designing experiments to evaluate UPF0114 protein BCI_0033 function, researchers should follow these methodological steps:

  • Define clear variables: Identify independent variables (protein concentration, buffer conditions, potential binding partners) and dependent variables (binding affinity, structural changes, downstream effects)

  • Formulate specific hypotheses: Based on sequence analysis and structural predictions, develop testable hypotheses about the protein's function

  • Implement controls: Include both positive controls (well-characterized proteins from the same family) and negative controls (buffer-only or irrelevant protein controls)

  • Use a systematic approach: Employ multiple complementary techniques (biochemical assays, structural studies, interaction analyses) to build a comprehensive understanding

  • Control for extraneous variables: Account for factors such as protein batch variation, buffer composition differences, and experimental conditions that might affect results

This experimental design approach will help establish cause-effect relationships between the protein and observed phenomena while minimizing confounding variables .

What are the key considerations for designing protein-protein interaction studies involving UPF0114 protein BCI_0033?

When designing protein-protein interaction studies with UPF0114 protein BCI_0033, consider the following methodological approaches:

  • Selection of appropriate tags: While His-tagged versions of the protein are commonly available, evaluate whether the tag position (N- or C-terminal) affects binding interfaces

  • Binding assay selection: Choose from:

    • Pull-down assays using immobilized BCI_0033

    • Surface Plasmon Resonance (SPR) for real-time binding kinetics

    • Isothermal Titration Calorimetry (ITC) for thermodynamic parameters

    • Crosslinking followed by mass spectrometry for binding site identification

  • Control experiments:

    • Use tag-only controls to rule out tag-mediated interactions

    • Include concentration gradients to determine binding specificity

    • Perform competition assays with related proteins to assess selectivity

  • Experimental validation: Employ at least two independent techniques to confirm identified interactions, as each method has inherent limitations and biases

  • Variable manipulation: Systematically alter conditions (pH, ionic strength, temperature) to characterize the nature of the interaction

This structured approach enhances the reliability and validity of protein interaction findings .

How can researchers correctly incorporate controls in experiments using recombinant UPF0114 protein BCI_0033?

Types of experimental controls to incorporate:

  • Negative controls:

    • Buffer-only samples to account for background signals

    • Unrelated proteins of similar size/properties to distinguish specific from non-specific effects

    • Denatured BCI_0033 to control for non-specific binding

  • Positive controls:

    • Well-characterized proteins from the same family

    • Known interacting partners of related proteins

    • Engineered variants with predicted functional alterations

  • Internal controls:

    • Multiple protein concentrations to establish dose-dependency

    • Time-course measurements to monitor reaction kinetics

    • Multiple batches of the protein to ensure reproducibility

  • Treatment controls:

    • Pre- and post-treatment comparisons

    • Gradient of treatment conditions to establish response curves

Control selection should align with your experimental design type (between-subjects or within-subjects) and account for potential carryover effects in sequential tests . This methodical control implementation significantly reduces the risk of confounding variables influencing your results .

What computational approaches can be utilized to predict the structure and function of UPF0114 protein BCI_0033?

Advanced computational methods can provide valuable insights into UPF0114 protein BCI_0033 structure and function:

  • Structural prediction methodologies:

    • AlphaFold2/RoseTTAFold: For high-accuracy 3D structure prediction

    • Molecular dynamics simulations: To explore conformational dynamics

    • Homology modeling: Using related structures as templates

    • Threading approaches: For identifying structural homologs with low sequence similarity

  • Functional prediction approaches:

    • Gene ontology enrichment: Based on sequence homology and domain architecture

    • Protein-protein interaction prediction: Using methods like SPRING, PIPE, or STRING

    • Binding site prediction: Through CASTp, SiteMap, or FTSite

    • Transmembrane topology prediction: Using TMHMM or Phobius (particularly relevant given the hydrophobic regions in the sequence)

  • Integrative analysis:

    • Combine sequence conservation, physicochemical properties, and predicted structural features

    • Employ machine learning approaches that integrate multiple data types

    • Utilize evolutionary coupling analysis to identify co-evolving residues indicating functional importance

  • Validation approaches:

    • Cross-validation using multiple prediction algorithms

    • Comparison with experimental data from related proteins

    • Identification of conserved motifs or residues across the UPF0114 family

This multilayered computational approach can guide experimental design by generating testable hypotheses about structure-function relationships in UPF0114 protein BCI_0033 .

How can researchers troubleshoot expression and purification issues with recombinant UPF0114 protein BCI_0033?

When encountering challenges with expression and purification of UPF0114 protein BCI_0033, implement this systematic troubleshooting approach:

Expression troubleshooting methodology:

  • Low expression yields:

    • Optimize codon usage for the host organism

    • Test multiple expression strains (BL21(DE3), Rosetta, etc. for E. coli)

    • Adjust induction parameters (temperature, inducer concentration, duration)

    • Consider alternate promoters or expression vectors

    • Test fusion partners that enhance solubility (SUMO, MBP, TRX)

  • Protein insolubility:

    • Reduce expression temperature (16-18°C)

    • Co-express with chaperones

    • Screen various lysis buffers with different detergents (for membrane proteins)

    • Implement on-column refolding techniques

    • Consider cell-free expression systems

Purification troubleshooting methodology:

  • Low binding efficiency to affinity resins:

    • Ensure tag accessibility (N vs. C-terminal positioning)

    • Optimize binding conditions (pH, salt concentration, imidazole)

    • Test alternate tag systems (His, GST, FLAG)

    • Use longer linkers between protein and tag

  • Protein aggregation during purification:

    • Add stabilizing agents (glycerol, trehalose, specific detergents)

    • Include reducing agents if cysteine residues are present

    • Optimize buffer composition and pH

    • Perform size exclusion chromatography at lower temperatures

  • Protein degradation:

    • Add protease inhibitors

    • Minimize purification time

    • Include EDTA (if compatible with your purification scheme)

    • Reduce purification temperature

This methodical approach helps identify specific bottlenecks in the expression and purification process, allowing for systematic optimization .

What are the approaches for analyzing post-translational modifications of UPF0114 protein BCI_0033 expressed in different systems?

Post-translational modifications (PTMs) of UPF0114 protein BCI_0033 may vary depending on the expression system. Here's a comprehensive methodology for PTM analysis:

System-specific PTM analysis approaches:

Expression SystemExpected PTMsRecommended Analysis Methods
E. coliMinimal (mainly phosphorylation)Phos-tag gels, LC-MS/MS with phospho-enrichment
YeastPhosphorylation, some glycosylationLC-MS/MS, glycan staining, lectin affinity
Insect cellsPhosphorylation, O-glycosylation, some N-glycosylationGlycosidase treatments, LC-MS/MS with ETD fragmentation
Mammalian cellsFull range of PTMs (phosphorylation, glycosylation, acetylation, etc.)Multi-enzyme digestion, comprehensive LC-MS/MS

Methodological workflow for PTM analysis:

  • Initial PTM screening:

    • Protein mobility shift assays (glycosylation, phosphorylation)

    • Staining with PTM-specific dyes (Pro-Q Diamond for phosphorylation, PAS for glycosylation)

    • Western blotting with PTM-specific antibodies

  • Mass spectrometry-based characterization:

    • Sample preparation with multiple proteases for improved coverage

    • Enrichment strategies for specific PTMs (TiO₂ for phosphopeptides, lectin affinity for glycopeptides)

    • Data-dependent acquisition with appropriate fragmentation methods (HCD, ETD, CID)

    • Targeted analysis of predicted modification sites

  • Functional validation of identified PTMs:

    • Site-directed mutagenesis of modified residues

    • Expression in systems with different PTM capabilities

    • Inhibitor studies to block specific modifications

    • Comparison of differentially modified protein activity

This systematic approach allows comprehensive characterization of PTMs in UPF0114 protein BCI_0033 expressed in different systems, providing insights into how these modifications might affect protein structure and function .

How should researchers approach contradictory results in functional studies of UPF0114 protein BCI_0033?

When faced with contradictory results in UPF0114 protein BCI_0033 studies, implement this systematic resolution methodology:

  • Analytical verification steps:

    • Protein identity confirmation: Verify protein sequence by mass spectrometry

    • Structural integrity assessment: Evaluate protein folding using circular dichroism or thermal shift assays

    • Batch-to-batch comparison: Test multiple protein preparations in parallel

    • Tag interference evaluation: Compare tagged versus untagged versions or different tag positions

  • Experimental design evaluation:

    • Variable identification: Catalog all variables between contradictory experiments

    • Controlled replication: Systematically modify single variables to identify sources of discrepancy

    • Blinded analysis: Implement blinded data collection and analysis to reduce bias

    • Statistical reassessment: Review statistical methods, sample sizes, and power calculations

  • Cross-validation approaches:

    • Orthogonal methods: Employ alternative techniques that measure the same parameter

    • Collaborative verification: Engage independent laboratories for confirmation

    • Positive control validation: Ensure positive controls behave as expected across all experimental conditions

  • Reconciliation strategies:

    • Context-dependency mapping: Define specific conditions where each result occurs

    • Mechanistic investigation: Formulate hypotheses explaining how contradictory results might reflect different aspects of protein function

    • Integrated model development: Create models incorporating apparently contradictory data into a cohesive framework

This systematic approach helps distinguish between genuine biological complexity and technical artifacts in contradictory results .

What methodological considerations are important when analyzing the membrane association properties of UPF0114 protein BCI_0033?

Analyzing the membrane association properties of UPF0114 protein BCI_0033 requires specialized methodological considerations:

  • Prediction-based analysis:

    • Hydropathy analysis: The amino acid sequence "MNKIIEKMIYESRWLLFPVYIGLSFGFILLTLKFFHEIIQFLPKIFDMPESDLILIVLSM IDIALVGGLLVMVMFSGYENFILKMSDDCNQKRLNWMGKMDVNSIKNKVASSIVAISSVH LLRIFMEADRTRDNKIMWCVIIHLAFVLSAFGMAYIDKMSKTKS" contains hydrophobic stretches consistent with potential membrane association

    • Topology prediction: Use algorithms like TMHMM, Phobius, or TOPCONS to predict transmembrane regions and orientation

    • Comparative analysis: Assess membrane association patterns of homologous UPF0114 family proteins

  • Experimental verification methods:

    • Membrane fractionation: Sequential ultracentrifugation to separate cellular compartments

    • Carbonate extraction: Distinguish peripheral from integral membrane proteins

    • Protease protection assays: Determine protein topology and exposed domains

    • Fluorescence microscopy: Using tagged versions to visualize cellular localization

  • Reconstitution approaches:

    • Liposome binding assays: Test association with artificial membranes of defined composition

    • Nanodiscs: Study protein behavior in a more native-like membrane environment

    • Detergent screening: Identify optimal solubilization conditions for structural and functional studies

  • Structural studies in membrane mimetics:

    • NMR with detergent micelles: For high-resolution structural information

    • Cryo-EM: For structural determination in larger membrane mimetics

    • FTIR spectroscopy: To assess secondary structure in membrane environments

This comprehensive approach enables reliable characterization of the membrane association properties of UPF0114 protein BCI_0033, critical for understanding its biological function .

How can the evolutionary significance of UPF0114 protein BCI_0033 be systematically investigated?

To systematically investigate the evolutionary significance of UPF0114 protein BCI_0033, implement this comprehensive methodological framework:

  • Phylogenetic analysis methodology:

    • Homolog identification: BLAST searches across diverse taxonomic groups

    • Multiple sequence alignment: Using MUSCLE, MAFFT, or T-Coffee algorithms

    • Tree construction: Maximum likelihood, Bayesian, and distance-based methods

    • Tree validation: Bootstrap analysis and comparison of tree topologies from different methods

  • Evolutionary pressure analysis:

    • dN/dS ratio calculation: To identify positions under purifying or positive selection

    • Conservation scoring: Using methods like ConSurf to map conservation onto predicted structures

    • Evolutionary trace analysis: To identify functionally important residues

    • Coevolutionary analysis: Identifying co-evolving residue networks suggesting functional linkages

  • Comparative genomics approaches:

    • Synteny analysis: Examining gene neighborhood conservation

    • Gene fusion events: Identifying domains that have fused with UPF0114 in different lineages

    • Horizontal gene transfer assessment: Evaluating phylogenetic incongruencies

    • Gene loss patterns: Mapping taxonomic distribution and loss events

  • Structural evolution investigation:

    • Ancestral sequence reconstruction: Inferring and characterizing ancestral forms

    • Structural comparison: Mapping sequence changes onto structural models

    • Domain architecture analysis: Tracking domain gain/loss events across evolution

    • Function prediction: Using evolutionary patterns to infer potential functions

This systematic evolutionary analysis can provide insights into the functional importance of UPF0114 protein BCI_0033, its adaptation in different organisms, and functional conservation or divergence patterns across species .

What cutting-edge techniques can be applied to determine the three-dimensional structure of UPF0114 protein BCI_0033?

State-of-the-art methodological approaches for determining the structure of UPF0114 protein BCI_0033 include:

This multi-technique approach provides complementary structural information and higher confidence in the determined structure of UPF0114 protein BCI_0033 .

What are the methodological approaches for studying potential binding partners of UPF0114 protein BCI_0033?

To comprehensively identify and characterize binding partners of UPF0114 protein BCI_0033, implement these methodological approaches:

  • Unbiased interaction discovery methods:

    • Affinity purification-mass spectrometry (AP-MS): Using His-tagged BCI_0033 as bait

    • BioID or APEX proximity labeling: For capturing transient interactions

    • Yeast two-hybrid screening: For direct protein-protein interactions

    • Co-immunoprecipitation followed by MS: For native complexes

  • Targeted interaction validation techniques:

    • Surface plasmon resonance (SPR): For binding kinetics and affinity

    • Microscale thermophoresis (MST): For interactions in solution

    • Isothermal titration calorimetry (ITC): For thermodynamic parameters

    • FRET/BRET assays: For interactions in cellular contexts

  • Structural characterization of complexes:

    • Cryo-EM of complexes: For visualization of interaction interfaces

    • Hydrogen-deuterium exchange MS: To map binding surfaces

    • Cross-linking MS: To identify residues in proximity

    • NMR chemical shift mapping: For identifying interaction surfaces

  • Functional validation approaches:

    • Mutagenesis of predicted interface residues: To disrupt specific interactions

    • Competition assays: To determine binding specificity

    • Cellular co-localization studies: For physiological relevance

    • Functional readouts: Measuring effects of disrupting interactions

  • Computational integration:

    • Network analysis: Placing identified interactions in broader cellular contexts

    • Molecular docking: Predicting binding modes of validated partners

    • Integrated scoring approaches: Combining multiple lines of evidence

This comprehensive interactomics strategy enables reliable identification and characterization of physiologically relevant binding partners of UPF0114 protein BCI_0033 .

What experimental designs are suitable for investigating the potential role of UPF0114 protein BCI_0033 in bacterial physiology?

For investigating the physiological role of UPF0114 protein BCI_0033 in bacterial systems, implement these experimental design approaches:

  • Genetic manipulation studies:

    • Gene knockout/knockdown: Using CRISPR interference or homologous recombination

    • Controlled expression systems: For titrated overexpression or complementation

    • Functional complementation: Testing if BCI_0033 can rescue phenotypes in related bacterial systems

    • Point mutants: Creating variants with altered predicted functional residues

  • Phenotypic characterization designs:

    • Growth curve analysis: Under various stress conditions (pH, temperature, osmotic pressure)

    • Membrane integrity tests: Using fluorescent dyes to assess permeability

    • Metabolomic profiling: To identify altered metabolic pathways

    • Transcriptomic response: RNA-seq to identify affected pathways

  • Localization and dynamics studies:

    • Fluorescent protein fusions: To track subcellular localization

    • FRAP analysis: To measure protein mobility

    • Super-resolution microscopy: For precise spatial organization

    • Time-lapse imaging: Under changing environmental conditions

  • Interaction with membrane components:

    • Lipid binding assays: To identify preferred membrane compositions

    • Detergent resistance: As measure of membrane microdomain association

    • Membrane potential measurements: To assess effects on membrane energetics

    • Ion flux measurements: To test potential transport functions

  • Comparative system analysis:

    • Multi-species phenotyping: Testing effects in different bacterial backgrounds

    • Heterologous expression: Expression of BCI_0033 in model organisms

    • Environmental response profiling: Under conditions mimicking natural habitat

    • In vivo competition assays: Between wild-type and mutant strains

These experimental design approaches provide a comprehensive framework for elucidating the physiological role of UPF0114 protein BCI_0033 in bacterial systems, following true experimental design principles of variable manipulation, randomization, and controlled observation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.